Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,127

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Chen, Y. Z., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,069

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Wu, A., Peng, Y., Huang, B., Ding, X. L., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,386

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,678

The Novel Coronavirus Originating in Wuhan, China

Phelan, A., Katz, R., & Gostin, L. O. (2020) · JAMA · doi:10.1001/jama.2020.1097 · Cited by 1,210

Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines

Whitt, M. A. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.08.006 · Cited by 431

A Host Receptor Nanodisc-Based Biosensor Platform for the Detection of a Specific Virus and Its Variants

Yoo, J. S., Park, I., Jwa, S., Lee, S. H., Hong, S., & Park, T. H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c01846 · Cited by 4

Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity

Zou, G.-Q., Li, K., Yan, C., Li, Y., Xian, M.-Y., Hu, X., Luo, R., & Liu, Z. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.07.046 · Cited by 4

Transmembrane protease serine 2 (TMPRSS2) inhibitors screened from an Fv-antibody library for preventing SARS-CoV-2 infection

Jung, J., Sung, J. S., Kwon, S., Bae, H. E., Kang, M., Jose, J., Lee, M., & Pyun, J. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00992d · Cited by 4

A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization

Cheng, Z., Sun, Y., Shen, Y., Wu, X., Pan, L., Wu, H., Bai, Y., Zhao, C., Ma, J., & Huang, W. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2467770 · Cited by 6

Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2

Iankov, I. D., Viker, K., Turgeon, C. T., Matern, D., & Galanis, E. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.112996 · Cited by 4

Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing

Li, Y., Wang, M., Wu, H., Zhao, H. J., Dong, L., Li, Y., Li, X., Tang, Y. M., Zhang, S., Li, J., et al. (2022) · Infectious Medicine · doi:10.1016/j.imj.2022.04.003 · Cited by 4

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study

Cao, C., Guo, Q., Dai, Y., Jiang, J., Liu, M., Ji, T., Zhou, P., & Gong, F. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2242217 · Cited by 4

A Delta–Omicron Bivalent Subunit Vaccine Elicited Antibody Responses in Mice against Both Ancestral and Variant Strains of SARS-CoV-2

Wang, T., Zheng, J., Xu, H., Wang, Z., Sun, P., Hou, X., Gong, X., Zhang, B., Wu, J., & Liu, B. (2023) · Vaccines · doi:10.3390/vaccines11101539 · Cited by 5

Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study

Li, Q., Lü, H., Ruan, Y., Geng, Y., Zhao, Z., Liu, Y., Feng, L., & Guo, W. (2024) · Antiviral Therapy · doi:10.1177/13596535241259952 · Cited by 4

Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020

Yuan, Y., Yu, L., Jin, Z., Wang, Y., Gao, M. Q., Ding, H., Zhuo, X., Zhu, X. M., Gao, F., Zheng, X., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.650487 · Cited by 4

Severe Acute Respiratory Syndrome Coronavirus 2 Virus-Like Particle and Its Application in Chinese Medical Research

Xu, R., Shi, M., Li, J., & Li, N. (2021) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_55_20 · Cited by 4

Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal

Wang, H., Zhang, L., Liang, Z.-T., Nie, J., Wu, J.-J., Li, Q.-Q., Ding, R., Zhang, Y., Chen, G., Wang, Y., et al. (2022) · Archives of Virology · doi:10.1007/s00705-021-05327-0 · Cited by 4

Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals

Hayer, J., & Urlaub, E. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02709-21 · Cited by 4

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs

Sun, W., He, L., Lou, H., Fan, W., Yang, L., Cheng, G., Liu, W., & Sun, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898520 · Cited by 4

A multiplex method for detection of SARS-CoV-2 variants based on MALDI-TOF mass spectrometry

Zhao, Z., Sun, L., Wang, L., Li, X., & Peng, J. (2023) · Biosafety and Health · doi:10.1016/j.bsheal.2023.02.003 · Cited by 4

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants

Gao, F., Zheng, M., Fan, J., Ding, Y., Liu, X., Zhang, M., Zhang, X., Dong, J., Zhou, X., Luo, J. F., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2186110 · Cited by 5

Staging of COVID-19 disease; using selected laboratory profiles for prediction, prevention and management of severe SARS-CoV-2 infection in Africa–review

Sendagire, H., Kiwuwa, S. M., Dhamani, A., Akugizibwe, R., Lwasa, Y., Bukenya, A., Kafeero, H. M., Kakeeto, P., Nankinga, Z., Bbosa, G. S., et al. (2023) · African Health Sciences · doi:10.4314/ahs.v23i1.2 · Cited by 4

SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine

Shuaib, W. M. A. W., Badaruddin, I. A., Mansor, M. M., Salleh, S. A., Hassan, M. R., Lindong, S., Samad, S. N., & Othman, H. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2266931 · Cited by 4

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques

He, Q., Mao, Q., Zhang, J., Gao, F., Bai, Y., Cui, B., Liu, J., An, C., Wang, Q., Yan, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949248 · Cited by 4

SARS-CoV-2 and Malayan pangolin coronavirus infect human endoderm, ectoderm and induced lung progenitor cellsPreprint

Hong, B., Lai, X., Chen, Y., Luo, T., An, X., Song, L., Zhuang, H., Fan, H., Li, T., Xiang, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.25.313270 · Cited by 4

Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and micePreprint

Sun, S., He, L., Zhao, Z., Gu, H., Fang, X. D., Wang, T., Yang, X., Chen, S., Deng, Y., Li, J., et al. (2020) · Research Square · doi:10.1101/2020.11.29.402339 · Cited by 4

Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study

Li, X., Yin, Y., Cui, Q., Huang, W., Zou, Q., & Shen, T. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28279 · Cited by 4

Magnetic bead-based electrochemical surrogate virus neutralization test for quantification of antibody neutralizing efficiency

Bellows, R. A., Rahn, K. L., Hummel, W. C., Mayton, E. H., Berry, H. W., Ryan, E. P., Geiss, B. J., Dandy, D. S., & Henry, C. S. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117640 · Cited by 3

A Safe and Accessible Cell-Based Spike–ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry

Rossotti, M. A., Ryan, S., Hussack, G., Tanha, J., Akache, B., & Renner, T. M. (2025) · Methods and Protocols · doi:10.3390/mps8050104 · Cited by 3

Heterologous SARS-CoV-2 Buccal Immunization with Oral Dissolving Films Generated a Strong Systemic and Mucosal Immunity in a Murine Model

Arte, T. M., Patil, S., Adediran, E. O., Gulani, M. A., Ferguson, A., Shah, S., Bagwe, P., Zughaier, S. M., & D’Souza, M. J. (2025) · Vaccines · doi:10.3390/vaccines13111105 · Cited by 3

Virome characterization of wild small mammals provides new insight into zoonotic pathogens in West Africa

Zhang, X.-A., Zhang, M.-Q., Liu, Y.-W., Lin, L., Zhang, J.-T., George, T., Jalloh, M., Sevalie, S., Kargbo, K., Jiang, B.-G., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02195-7 · Cited by 3

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models

Batra, H., Luo, S., Saunders, K. O., Higgins, J. S., Jian, F., Zhang, J., Kibria, M. G., Jonaid, G. M., Zhou, Q. J., Eaton, A., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2537053123 · Cited by 4

Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity?

Hardy, E., & Fernández-Patrón, C. (2022) · Cells · doi:10.3390/cells11192955 · Cited by 3

Advancements in COVID-19 Testing: An In-depth Overview

Kumar, R., Harilal, S., Al-Sehemi, A. G., Pannipara, M., Mathew, G. E., & Mathew, B. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220921144150 · Cited by 3

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors

Curreli, F., Chau, K., Tran, T.-T., Nicolau, I., Ahmed, S., Das, P., Hillyer, C. D., Premenko-Lanier, M., & Debnath, A. K. (2023) · Viruses · doi:10.3390/v15041001 · Cited by 3

Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank

Kajova, M., Khawaja, T., Levonen, I., Pietilä, J.-P., Virtanen, J. M. E., Pakkanen, S. H., Välimaa, H., Nousiainen, A., Hepojoki, J., Sironen, T. A., et al. (2024) · New Microbes and New Infections · doi:10.1016/j.nmni.2024.101525 · Cited by 3

Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes

Neerukonda, S. N., Vassell, R. A., Lusvarghi, S., Liu, S., Akue, A. D., KuKuruga, M. A., Wang, T. T., Weiss, C. D., & Wang, W. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02808-24 · Cited by 4

Establishment and Analysis of Spatiotemporal Variation Hydrological Model of Distributed Rainfall and Evaporation in Biliu River Basin

Liu, Q., Zhao, X., Wang, H., & Sun, Y. (2021) · Complexity · doi:10.1155/2021/6639691 · Cited by 3

Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals

Stelitano, D., Weisberg, S. P., Goldklang, M. P., Zhu, Y., Bovier, F. T., Kalantarov, G., Greco, G., Décimo, D., Franci, G., Cennamo, M., et al. (2021) · mSphere · doi:10.1128/msphere.00571-21 · Cited by 3

Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter

Sergeeva, M. V., Pulkina, A., Romanovskaya-Romanko, E., Mustafaeva, A., Egorov, A., & Stukova, M. (2022) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683822070067 · Cited by 3

Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern

Zhang, T., Wang, Z., Yang, J., & Xu, X. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28563 · Cited by 3

Immunological tests: Essential and supportive tools in the fight against COVID-19

Zhang, D., Kukkar, D., & Kim, K. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117291 · Cited by 3

Collaborative effects of 2019-nCoV-Spike mutants on viral infectivity

Fang, S., Lei, C., Li, M., Ming, Y., Liu, L., Zhou, X., & Li, M. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.030 · Cited by 3

Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial

Jia, S., Zhang, J., Wang, X., Zhang, Z., Wang, B., Zhang, J., Jiang, H.-D., Guo, G., Wang, Y., Wan, J., et al. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00892-0 · Cited by 3

Rational prediction of immunogenicity clustering through cross‐reactivity analysis of thirteen SARS‐CoV‐2 variants

Liang, Z., Tong, J., Sun, Z., Liu, S., Wu, J., Wu, X., Li, T., Yu, Y., Zhang, L., Zhao, C., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29314 · Cited by 3

Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad

Wondeu, A. L. D., Abakar, M. F., Frasca, F., Nodjikouambaye, Z. A., Zakaria, F. A., Naïbeï, N., Dzomo, G. R. T., Djimtoïbaye, D., Mad-Toïngué, J., Scagnolari, C., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1154 · Cited by 3

Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development

Li, X., Zeng, F., Yue, R., Ma, D., Meng, Z., Li, Q., Zhang, Z., Zhang, H., Liao, Y., Liao, Y., et al. (2024) · Vaccines · doi:10.3390/vaccines12020120 · Cited by 3

APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution

Shen, J., Xu, X., Fan, J., Chen, H., Zhao, Y., Huang, W., Liu, W., Zhang, Z., Cui, Q., Li, Q., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32139 · Cited by 3

Which test results to believe? Comparison of different ELISA kits for detection of SARS-CoV-2-neutralizing antibody among COVID-vaccinated individuals

Yanamandra, U., Tandel, K., Rayapureddi, K., Singh, S. P., Arivalagan, B., Kalra, D. K., Sahu, R., Menon, A. S., & Kotwal, N. (2024) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2024.05.014 · Cited by 3

Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population

Jiang, Q., Wu, X., Dong, F., Qiao, S., Shi, Q., Jian, C. Y., Chen, C., Zhou, J., Wang, Y., & Huang, W. (2024) · Biosafety and Health · doi:10.1016/j.bsheal.2024.09.002 · Cited by 3

A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology

Liu, H., Liu, T., Wang, A., Liang, C., Zhu, X., Zhou, J., Chen, Y., Liu, Y., Qi, Y., Chen, W., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03574 · Cited by 3

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies

Jung, B. K., Yoon, J. H., Bae, J., Kim, J., Park, M., Lee, S. Y., & Lim, C. S. (2021) · Diagnostics · doi:10.3390/diagnostics11122193 · Cited by 3

Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors

Lu, B., Zhu, K.-L., Cui, X.-M., Lin, Y., Wang, X., Wang, G., Duan, L., Qian, A., & Ma, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109103 · Cited by 3

Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins

Jirarojwattana, P., Shanmugaraj, B., Rattanapisit, K., & Phoolcharoen, W. (2023) · Biotechnology Reports · doi:10.1016/j.btre.2023.e00796 · Cited by 3

tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains

Ivanusic, D., Maier, J. M., Icli, S., Falcone, V., Bernauer, H. S., & Bannert, N. (2024) · iScience · doi:10.1016/j.isci.2024.109123 · Cited by 3

Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein

Zhou, Y.-F., Nie, J., Shi, C., Ning, K., Cao, Y., Xie, Y., Xiang, H., & Xie, Q. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2205.05023 · Cited by 3

Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike

Mekkaoui, L., Bentley, E. M., Ferrari, M., Lamb, K., Ward, K., Karattil, R., Akbar, Z., Bughda, R., Sillibourne, J., Onuoha, S. C., et al. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4194 · Cited by 3

Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimenPreprint

Li, Y., Fang, X. D., Pei, R., Fan, R., Chen, S., Zeng, P., Ou, Z., Deng, J., Zhou, J., Sun, Z., et al. (2021) · medRxiv · doi:10.1101/2021.11.04.21265780 · Cited by 3

AQP4-DARPin1: A Chimeric Antigen Based on Scaffold Protein DARPin for Efficient Detection of AQP4-IgG in NMOSD

Wang, X., Ma, S., Bai, Y., Wu, X., Ji, F., & Jia, L. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00688 · Cited by 2

Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination

Hiranburana, N., Thippamom, N., Avihingsanon, A., Wacharapluesadee, S., Ubolyam, S., Kerr, S. J., Tan, C. W., Wang, L., & Putcharoen, O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317940 · Cited by 2

Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin

Fuochi, V., Furnari, S., Drago, F., & Furneri, P. M. (2025) · Biomolecules · doi:10.3390/biom15070931 · Cited by 2

Application of Orthoflavivirus Pseudovirus Technology in Antiviral Research

Zhang, Y., Zhao, Y., Wang, C., Zhou, Y., Yuan, H., Li, X., Wang, Y. M., & Pan, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020722 · Cited by 2

Single molecule force spectroscopy for evaluating inhibitors of SARS-CoV-2 variants of concern

Zhu, R., Oh, Y. J., & Hinterdorfer, P. (2026) · European Biophysics Journal · doi:10.1007/s00249-026-01818-7 · Cited by 2

CuInP 2 S 6 Captures Virus for Viral Inhibition and Vaccine Adjuvanticity

Chen, J., Zhang, G., Liu, F., Li, X., Li, S., Liu, Y., Yang, C., Pierleoni, G., Li, H., Li, Q., et al. (2026) · Nano Letters · doi:10.1021/acs.nanolett.5c04910 · Cited by 2

Low-entry-barrier point-of-care testing of anti-SARS-CoV-2 IgG in the population of Upper Austria from December 2020 until April 2021—a feasible surveillance strategy for post-pandemic monitoring?

Doppler, C., Feischl, M., Ganhör, C., Puh, Š., Müller, M., Kotnik, M., Mimler, T., Sonnleitner, M., Bernhard, D., & Wechselberger, C. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-03966-z · Cited by 2

Pseudotyped Viruses for Mammarenavirus

Li, Q., Huang, W., & Wang, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_15 · Cited by 2

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice

An, Z., Zhang, Y., Yu, X., Jia Hui, X. I. A., Yin, Y., Li, G., Lu, J., Fan, X., & Xu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051412 · Cited by 3

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation

Yu, Y., Zhang, M., Huang, L. F., Chen, Y., Wu, X., Li, T., Li, Y., Wang, Y., & Huang, W. (2024) · Viruses · doi:10.3390/v16050763 · Cited by 2

Development of a colloidal gold-based immunochromatographic assay for rapid detection of nasal mucosal secretory IgA against SARS-CoV-2

Sun, B., Chen, Z., Feng, B., Chen, S. E., Feng, S., Wang, Q., Niu, X., Zhang, Z., Zheng, P., Lin, M., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1386891 · Cited by 2

Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China

Li, J., Xu, J., Liu, Y., Chen, L., Yu, L., Xiao, X., & Wang, Q. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2389602 · Cited by 2

Preventing SARS-CoV-2 infection using Fv-antibodies targeting the proprotein convertase (PPC) cleavage site

Jung, J., Sung, J. S., Kwon, S., Bae, H. E., Kang, M., Jose, J., Lee, M., & Pyun, J. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00552j · Cited by 2

Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2

Jung, J., Kwon, S., Sung, J. S., Bae, H. E., Kang, M., Jose, J., Lee, M., & Pyun, J. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00441 · Cited by 2

Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants

Kim, T.-H., Bae, S., & Myoung, J. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2411.11001 · Cited by 2

Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay

Ali, D. W., Bartlett, M. L., Heger, C. D., Ramirez, F., Johnson, L., Schully, K. L., Laing, E. D., Wang, W., Weiss, C. D., Goguet, E., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00083-9 · Cited by 3

Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA

Zhang, X., Jia, J., Hu, C., Fu, Y., Liu, G., Li, Y., He, Q., Gao, F., Li, N., Wang, L., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571418 · Cited by 2

Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1

Zydek, I., Thümmler, L., Beckmann, N., Sehl, C., Soddemann, M., Grüneberg, R., Elsner, C., Kamler, M., Dittmer, U., Witzke, O., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1631947 · Cited by 3

Establishment of Emergency Teaching Model and Optimization of Discrete Dynamic Calculation in Complex Virtual Simulation Environment

Li, H., Sun, Y., Song, K., & Yin, C. (2022) · Mathematical Problems in Engineering · doi:10.1155/2022/6767237 · Cited by 2

A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China

Xu, R.-J., Zhao, B.-N., Lan, L.-J., Liu, Y.-L., Li, Y.-L., Jiang, L.-S., & Dai, S.-P. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.71286 · Cited by 1

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants

Jia, L., Zhou, Y., Li, S., Zhang, Y., Yan, D., Wang, W., Zhang, W., Wan, Y., & Qiu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897879 · Cited by 2

Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19

Feng, J., Wang, W.-J., Jin, P., Zheng, H., Jin, L., Xia, X., Zhang, X., Li, Z.-P., Li, J., & Zhu, F. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2230760 · Cited by 2

Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection

Bhattacharjee, B., Rynjah, D., Ahmed, A. B., Newar, A., Sengupta, S., Chakrabarty, S., Sahu, R. K., & Khan, J. (2024) · Chemical Papers · doi:10.1007/s11696-023-03271-8 · Cited by 2

Testing the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein

Garg, P., Hsueh, S. C. C., & Plotkin, S. S. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.03.018 · Cited by 2

Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection

Stich, M., Magalhães, V. G., Bürger, F., Garbade, S. F., Jeltsch, K., Möhr, K., Haddad, A. D. M., Elling, R., Lang, P., Rabsteyn, A., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70098 · Cited by 2

Obstacles in the road of biomedical research on COVID-19 in Jordan: Poor funding and beyond

Qaqish, A., Al-Omari, M., & Dajani, R. B. (2022) · Journal of Global Health · doi:10.7189/jogh.12.03052 · Cited by 2

Assays Based on Pseudotyped Viruses

Nie, J., Wu, X., & Wang, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_2 · Cited by 2

A Natural Bioactive Peptide from Pinctada fucata Pearls Can Be Used as a Potential Inhibitor of the Interaction between SARS-CoV-2 and ACE2 against COVID-19

Wang, Y., Wang, Q., Chen, X., Li, B., Zhang, Z., Yao, L., Liu, X., & Zhang, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147902 · Cited by 2

SARS-CoV-2 Laboratory Testing in India's Pandemic Response: A Public Health Perspective

Moorthy, M., & Fletcher, G. J. (2020) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_491_20 · Cited by 2

Persistent Antibody Responses to SARS-CoV-2 Infection in Cancer Patients: A Single-Center Retrospective Observational Study

Agarwal, A., Baghmar, S., Qureshi, S. R., Khurana, A., Setia, R., Khan, M. A., Barman, P., Kapoor, R. K., Hasthavaram, N. R., Kumar, R., et al. (2021) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0041-1733823 · Cited by 2

Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples

Filchtinski, D., Sundberg, M., Berthold, H., Steller, L., Kayser, J., Holz, S., Hinze, M., Braeutigam, O., Schulte-Pelkum, J., & Fiedler, R. (2022) · Journal of Immunological Methods · doi:10.1016/j.jim.2022.113258 · Cited by 2

Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose

Zhao, D., Wang, X., Liu, J., Chinnappa, A. U., Basavaraj, V., Sri, C. D., Nikolenko, V. N., Beeraka, N. M., Shivaprakash, P., & Fan, R. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230227115329 · Cited by 2

Evaluation of Neutralizing Antibodies against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus (Vsv) Pseudovirus-Based AssayPreprint

Almahboub, S. A., Algaissi, A. A., Alfaleh, M. A., ElAssouli, M.-Z. M., & Hashem, A. M. (2020) · Preprints.org · doi:10.20944/preprints202005.0379.v1 · Cited by 2

LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patientsPreprint

Bombaci, G., Sarangdhar, M. A., Andina, N. D., Tardivel, A., Yu, E. C.-W., Mackie, G. M., Pugh, M., Ozan, V. B., Banz, Y., Spinetti, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.12.438219 · Cited by 2

A scalable pipeline for SARS-CoV-2 replicon construction based on de-novo synthesisPreprint

Berkyurek, A. C., Lee, E., Weissbrod, O., Rasnic, R., Falciatori, I., Chen, S., & Erlich, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.05.478644 · Cited by 2

A Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial CellsPreprint

Ma, Y., Mao, G., Wu, G., Chen, M., Qin, F., & Zhang, X. (2020) · Research Square · doi:10.21203/rs.3.rs-112689/v1 · Cited by 2

Diagnostics and Monitoring of COVID-19 Infection – Current UnderstandingPreprint

Bergant, M., & de Marco, A. (2020) · Preprints.org · doi:10.20944/preprints202005.0316.v1 · Cited by 2

Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak

Zhang, S., Tang, L., Bao, C., Wang, S., Li, B., Huang, L., Song, H., Fu, J., Xu, Z., Meng, F., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.7304 · Cited by 1

Development and application of a high-titer VSV-based HCoV-NL63 pseudovirus system via C-terminal 14 amino acid truncation of spike

Shao, L., Wang, M., Wang, Y.-M., Li, T., Wang, F., Xin, J.-R., Zhang, X., Li, W.-G., Wang, X., & Wang, S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151458 · Cited by 1

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar

Vaikath, N. N., Al‐Nesf, M. A., Majbour, N. K., Abdesselem, H., Gupta, V., Bensmail, I., Abdi, I. Y., Elmagarmid, K. A., Shabani, S., Sudhakaran, I. P., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102744 · Cited by 1

Cross-neutralization effect of the third dose of inactivated COVID-19 vaccine against the SARS-CoV-2 variants

Li, Y., He, J., Liu, W., Qi, R., Li, J., & Zhu, F. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2550984 · Cited by 1

An in vivo NanoBiT-based pseudoviral biosensor for real-time monitoring of SARS-CoV-2 spike/hACE2 interactions and therapeutic screening

Lin, C., Lin, M., Yang, X., Chiang, H.-H., Wu, T.-H., Tsai, C.-H., & Lin, C. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344623 · Cited by 1

Highly reliable LFIA assay reveals long-term real-world dynamics of neutralizing antibodies against SARS-CoV-2

Chen, C., Wu, J., Ren, Y., Ji, J., Meng, R., Yang, Z., Zhao, Y., Xue, M., Li, X., Wang, L., et al. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.06.043 · Cited by 1

Pseudotyped Viruses for Coronaviruses

Wang, M., Nie, J., & Wang, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_7 · Cited by 1

Overexpression of human ACE2 protein in mouse fibroblasts stably transfected with the intact ACE2 gene

Teng, F., Gang, O., & Freimuth, P. (2024) · Virology · doi:10.1016/j.virol.2024.109988 · Cited by 1

Targeted protein editing technique in living mammalian cells by peptide-fused PNGase

Wu, M., Bai, G., Zhang, Z., Xiao, H., Sun, W., & Tian, C. (2024) · hLife · doi:10.1016/j.hlife.2024.07.003 · Cited by 1

Epidemiological and immunological characteristics of middle-aged and elderly people in housing estates after Omicron BA.5 wave in Jinan, China

Zhao, X.-J., Li, M., Zhang, S., Li, K., Wei, W.-Q., Chen, J., Xu, Q., Lv, C., Liu, T., Wang, G., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38382 · Cited by 1

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Nie, J., Li, Q., Wu, J., Zhao, C., Hao, H., Liu, H., Zhang, L., Nie, L., Qin, H., Wang, M., et al. (2020) · Nature Protocols · doi:10.1038/s41596-020-0394-5 · Cited by 427

Detection of Neutralizing Antibodies in Serum Samples Using a SARS‐CoV‐2 Pseudotyped Virus Assay

Ferrero, S., Batto, M. V., Gatto, M. I., Dimase, F., & Helguera, G. F. (2024) · Current Protocols · doi:10.1002/cpz1.70025

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay

Tolah, A. M., Sohrab, S. S., Tolah, K. M., Hassan, A. M., El-Kafrawy, S. A., & Azhar, E. I. (2021) · Diagnostics · doi:10.3390/diagnostics11060994 · Cited by 34

Design and Development of a Pseudotyped-lentivirus for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hassannia, H., Enderami, S. E., Mansour, R. N., Eftekhary, M., Abazari, M., & Salarinia, R. (2023) · DOAJ (DOAJ: Directory of Open Access Journals)

Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2

Balinsky, C. A., Jani, V., Sun, P., Williams, M., Defang, G. N., & Porter, K. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2111-0_21 · Cited by 5